SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/10/22 AVROBIO, Inc. 8-K:5,9 6/08/22 11:205K ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 35K 2: EX-10.1 Material Contract HTML 16K 6: R1 Document and Entity Information HTML 51K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- avro-8k_20220608_htm XML 15K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- avro-20220608_lab XML 62K 5: EX-101.PRE XBRL Presentations -- avro-20220608_pre XML 38K 3: EX-101.SCH XBRL Schema -- avro-20220608 XSD 18K 10: JSON XBRL Instance as JSON Data -- MetaLinks 13± 20K 11: ZIP XBRL Zipped Folder -- 0001564590-22-022999-xbrl Zip 13K
SECOND AMENDMENT TO THE AVROBIO, INC.
2018 STOCK OPTION AND INCENTIVE PLAN
This Second Amendment (this “Amendment”) to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan (the “Plan”), of AVROBIO, Inc. (the “Company”) is effective as of the date of approval by the Company’s stockholders (the “Effective Date”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Plan.
As of the Effective Date, the Plan shall be amended as follows:
1.Section 3(a) of the Plan is hereby deleted in its entirety and replaced with the following:
(a)Stock Issuable. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be 13,486,099 shares, subject to adjustment as provided in Section 3(c). For purposes of this limitation, the shares of Stock underlying any Awards under the Plan and under the Company’s Amended and Restated 2015 Stock Option and Grant Plan that are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) (including, for the avoidance of doubt, any such shares of Stock that are subject to such treatment between March 2, 2022 and the Effective Date) shall be added back to the shares of Stock available for issuance under the Plan. In the event the Company repurchases shares of Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject to such overall limitation, the maximum aggregate number of shares of Stock that may be issued in the form of Incentive Stock Options shall not exceed 40,458,297, subject in all cases to adjustment as provided in Section 3(c). Subject to such overall limitations, shares of Stock may be issued up to such maximum number pursuant to any type or types of Award. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company.
2. |
A new Section 3(e) of the Plan is hereby inserted as follows: |
|
(e) |
Minimum Vesting. Subject to Sections 2(b)(v) and 3(d), any Awards that settle in Stock (other than such Awards representing a maximum of five percent (5%) of the Stock reserved for issuance under this Plan, subject to adjustment as provided in Section 3(c)) shall be granted subject to a minimum time-vesting period of at least twelve (12) months, such that no such Awards shall vest prior to the first anniversary of the applicable grant date. |
3. |
The second sentence of Section 19 of the Plan is hereby deleted in its entirety and replaced with the following: |
No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Effective Date or the effective date of stockholder approval of any amendment to add shares to the Plan, and no grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the date the Plan (or most recent amendment to add shares to the Plan) is approved by the Board.
4. |
Except as expressly amended by this Amendment, the Plan shall continue in full force and effect in accordance with the provisions thereof. |
[signature page to follow]
IN WITNESS WHEREOF, the Company has caused this Amendment to be duly executed as of March 2, 2022.
AVROBIO, INC. |
|
|
|
By: |
/s/ Geoff MacKay |
|
Name: Geoff MacKay |
|
Title: CEO and President |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/10/22 | 4 | ||
For Period end: | 6/8/22 | 3, 4, DEF 14A | ||
3/2/22 | ||||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 11/08/22 AVROBIO, Inc. S-3 8:1.8M Broadridge Fin’l So… Inc 8/09/22 AVROBIO, Inc. S-8 8/09/22 4:62K Broadridge Fin’l So… Inc 8/09/22 AVROBIO, Inc. 10-Q 6/30/22 65:7.3M Donnelley … Solutions/FA |